An Investigation Into an Objective Measure of Muscle Quality, Function and Ability

NCT ID: NCT04269291

Last Updated: 2022-03-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-18

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The assessment of muscular function, quality and ability is of high importance in a diverse range of clinical disciplines from anaesthetics to physiotherapy. This study will look at the range of measurement techniques currently in use and development and considers their effectiveness and objectivity. It will also investigate whether an objective measurement technique can be found or developed that can be used both in the clinical environment and the community setting. This will focus on upper limb function and ability; ability is used here instead of strength since ability better describes functions needed for daily living rather than the maximum output a muscle is capable of.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A literature review (available on request) explores what can be measured, the problems of measurement and its objectivity. The aim is to investigate whether there is a method of measuring muscle quality, function and ability that can be used objectively in the clinical environment or the community with equal ease or whether such a method can be developed.

The literature review identified electrical impedance myography (EIM) as a potentially objective technique to measure muscle quality and ability. Two hypotheses are proposed to test the objectivity:

The EIM measurement of passive and active muscle is not significantly different.

EIM measurements in younger and older adult volunteers is significantly different.

There is only one study visit for this study, so all study activities will occur on the same day at the Posture and Mobility Centre, Treforest or the Artificial Limb and Appliance Centre, Rookwood Hospital.

Eligibility for the study will be checked against the inclusion and exclusion criteria, including the requests to not have done heavy exercise for an hour before the measurements and also to have emptied their bladder before attending for the visit.

Any concerns will be also be addressed appropriately

Following the eligibility check, the CI will ensure the participant has read the PIS and fully understand it before obtaining informed consent.

Participants will be assigned a number in order to anonymise their data and only the main investigator will have access to this database of participants.

The following data will then be collected by the CI and written in a Case Report Form (CRF):

* Gender
* Date of birth (to ascertain age)
* Height (to calculate BMI)
* Weight (to calculate BMI)
* Waist measurement (to calculate RFM index, considered an alternative indicator of health).
* Medical history to ensure no existing neuromuscular, active arthritis or cardiac conditions or active implanted devices
* Perceived level of fitness - using the NHS scale https://www.nhs.uk/live-well/healthy-weight/bmi-calculator/ (to gauge muscle ability)
* A quantitative measurement method will be used in conjunction with a structured initial questionnaire relating to physical characteristics (e.g. height, weight, waist measurement, date of birth to indicate age and perceived level of fitness https://www.nhs.uk/live-well/healthy-weight/bmi-calculator/).

The CI will then attach electrodes to the arm of the participant and they will be asked to relax for 10 minutes.

The measurement device is an ImpediMed IMP SFB7 (CE 0129 marked) and is portable. EIM passes an imperceptible AC current (less than 1 mA) through the muscle under investigation and the impedance of that muscle is then recorded through a range of frequencies or at chosen frequencies.

Measurements of EIM of the relaxed muscles will be recorded in the CRF followed by measurements of EIM in the contracted muscle.

Electrodes will be carefully removed from the participant and they are invited to relax for a further 5 minutes and have a drink of water.

The participant's involvement in the study will end after the measurements have been taken.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Electric Impedance Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be volunteers
* be over the age of 18
* no pre-existing neuromuscular disease
* not have an implanted cardiac device
* be well at the time of measurement
* be able to give informed consent

Exclusion Criteria

* Any existing neuromuscular disorder (eg multiple sclerosis, ALS, MND, CP)
* Any existing cardiac disease (including having a pacemaker or ICD)
* Active arthritis
* Be pregnant
* Any other implanted electrical device
* Not able to give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cardiff and Vale University Health Board

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephanie Wentworth

Chief Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephanie Wentworth

Role: PRINCIPAL_INVESTIGATOR

[email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiff and Vale University Health Board.

Cardiff, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7703

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.